Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Canada Postdoctoral Research Award (CPRA) program

University of Toronto

$140,000.00

Discovery and characterization of novel natural product antifungals

FY 2025-26

Summary
Fungal infections cause millions of human deaths every year, and treating these infections gets more challenging as fungal pathogens are becoming resistant to the few antifungal drugs available. To prevent these deaths and combat resistant fungal infections, new antifungal drugs are needed. Many of the best antimicrobial drugs originated as natural products, chemicals produced by living organisms - typically soil bacteria or fungi. In nature, antimicrobials likely help organisms compete for resources. In this project, we will isolate antifungal natural products from extracts taken from a diverse collection of organisms. The most promising compounds will be tested for their ability to inhibit the growth of a large panel of fungal pathogens. Further, these compounds will be evaluated in an infection model for protection from fungal pathogens. From the compounds that succeed in these tests, we will use genetics and biochemical methods to determine their molecular target and mechanism of action. We anticipate that this project will identify promising antifungal compounds that act differently from and add to our limited antifungal arsenal.
Program
Canada Postdoctoral Research Award (CPRA) program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
537751
Name
Yaeger Luke N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Discovery and characterization of novel natural product antifungals
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Drug Discovery; Fungal Infections; Infectious Disease; Mechanism Of Action; Natural Products
Abstract
Fungal infections cause millions of human deaths every year, and treating these infections gets more challenging as fungal pathogens are becoming resistant to the few antifungal drugs available. To prevent these deaths and combat resistant fungal infections, new antifungal drugs are needed. Many of the best antimicrobial drugs originated as natural products, chemicals produced by living organisms - typically soil bacteria or fungi. In nature, antimicrobials likely help organisms compete for resources. In this project, we will isolate antifungal natural products from extracts taken from a diverse collection of organisms. The most promising compounds will be tested for their ability to inhibit the growth of a large panel of fungal pathogens. Further, these compounds will be evaluated in an infection model for protection from fungal pathogens. From the compounds that succeed in these tests, we will use genetics and biochemical methods to determine their molecular target and mechanism of action. We anticipate that this project will identify promising antifungal compounds that act differently from and add to our limited antifungal arsenal.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Yaeger, Luke N
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~